Potential treatment for neurological disorders targets brain cells
UCL researchers have developed a possible new treatment for neurological and psychiatric diseases, that works by reducing the excitability of overactive brain cells.
List view / Grid view
UCL researchers have developed a possible new treatment for neurological and psychiatric diseases, that works by reducing the excitability of overactive brain cells.
US scientists have found strong evidence for testing VCU-manufactured drugs in liver cancer.
Researchers show how monkeypox mutations cause virus to replicate, spread faster.
A new study found that as patients age, Huntington’s disease gradually impairs the important cellular housekeeping process autophagy, which is responsible for eliminating waste from cells.
UPF and John Hopkins scientists have discovered how cancer cells exposed to high viscosity environments change their movements to improve their invasiveness and favour metastases.
Spanish researchers have discovered that vitamin C may hold the key to improving the efficacy of dendritic cell-derived anticancer therapies.
The NPGPx protein is active in foetuses, but largely dormant and absent in diabetic adults.
Streamline your cancer research using this guide that groups antibodies against critical cancer biomarkers according to biomarker type or tissue type.
MIT researchers have developed a technique that could help the production of monoclonal antibodies and other useful proteins.
Researchers from the University of California have developed the first pre-clinical model of appendiceal cancer, containing all elements of the tumour.
A recent study in mice revealed that an ion channel already proven to affect blood pressure in obese mice plays a role in suppressing their breathing, influencing sleep apnoea.
Researchers have used AI to design microneedle patches that restore hair in balding mice.
In the production of RNA, researchers in Spain and Denmark have found a method for attacking cancer cells.
Tune in to this podcast to hear experts discuss 3D cell models, organoids and the automation of complex cell assays.
1 November 2022 | By Standard BioTools
Watch our on-demand webinar to hear about advances toward precision medicine through the use of cutting-edge methods and analysing critical patient immune data in response to therapies and disease progression.